Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

ClinicalTrials.gov ID: NCT00000888

Public ClinicalTrials.gov record NCT00000888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Trial of the Safety, Tolerance, and Pharmacokinetics of Oral Ritonavir Co-Administered With Lamivudine (3TC) and Zidovudine (ZDV) in HIV-1-Infected Pregnant Women and Their Infants

Study identification

NCT ID
NCT00000888
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
14 participants

Conditions and interventions

Interventions

  • Ritonavir Drug
  • Lamivudine Drug
  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Mar 31, 2001
Last update posted
Oct 28, 2021

Ends 2001

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Univ. of Miami Miller School of Medicine - Jackson Memorial Hosp. Miami Florida 33136
Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami Florida 33161
Children's Hospital of Michigan NICHD CRS Detroit Michigan 48201
Regional Med Ctr at Memphis Memphis Tennessee 38103
St. Jude/UTHSC CRS Memphis Tennessee 38105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →